Member Info for HarChris

It’s usually six months on AIM Malco - that’s probably where the confusion stems from.

Haven't you just speculated there somewhat? We don't know that the 'auditors are not happy with the evidence presented to support the account entries provided by the company directors, hence the extra questions.'

There are other possible explanations too. Perhaps they've all come down with gastric flu?!

20th Feb 2023 7:00 am RNS Contract wins

17th Feb 2023 7:00 am RNS Methil Update

16th Feb 2023 7:00 am RNS Cory Barges Update

They've got form as I said... Scilly contract news tomorrow please!

Possibly JW playing the AIM game too, wanting to keep the momentum from yesterday (he has form for putting out rns' on consecutive days) - no complaints from me.

Yeah you're out by a factor of ten, revenue to mcap isn't all that impressive but it's the EBITDA that's off the charts... looking at $60-$70m EBITDA vs $130m market cap and that can be improved upon in 2024...

Factor in relatively low debt already and the undervaluation becomes pretty evident.

I'm not sure anything dodgy is going on, there's just not the sustained buying pressure to move this significantly north.

It will come, give it time. Nice to see POG back on the tail of $2k/oz

Stocks, especially small caps, are suddenly back in favour. There's a rather big opportunity cost in holding Argo right now and just sitting there waiting in vain for a bitcoin pump with the market turning risk on.

I wouldn’t expect much from the full year report later, it’s backwards looking and everything good is in front of TGR…

A post period update that points to all being on track would certainly go down well though with a more thorough operational update in the coming weeks signposted.

As a Yourgene holder with any sense you’d sell now if you think there’s any chance the deal fails to go through (be it collapsing or voted down) as the SP will plummet given that scenario.

Maybe they are nervous nellies like you?

Relax, all is good. We are v close to the point where TGR’s favourable fundamentals will be clear for all to see.

From Alastair’s comments it’s reasonable to infer that there’s a fairly high chance (greater than 50/50?) that MTD is found in cohort 6. If it’s not then it’s reasonable to infer a very high chance (greater than 75/25?) of finding it in cohort 7 and even then if they don’t there’s no reason to suggest they’d go back on their plan to use a biologically effective dose.

Hence p1a will be over in the not too distant future either way with all the data that’s needed.

The past two years there was a covid extension of two months, otherwise for main market companies it’s four months after YE.

Yeah, I expect it will come after hours.

Been focusing on the wrong things for too long here…

What matters is the content of the q2 results, not what day it lands.

It's quite clear that HUM is a riskier more leveraged play on gold than the miner I'm currently invested in (Shanta) but with even bigger upside potential if POG continues to play ball through the rest of 2023 and 2024.

More research needed but will probably look to open a position here, thanks for the replies.

Yeah that's the only way of making money here now, timing speculative pumps however unlike a memecoin Argo is actually likely to become insolvent and go out of business due to non repayable debt.

I'd argue memecoins are a safer play.

I only ask that as I see they got a placing away sub 8p earlier in the year and this would seem like a reasonable opportunity to fast track the slashing of debt whilst also slightly insuring against any retrace in the POG.

Quick question as I've started looking into HUM, how much of the debt is needing to be paid off in the short term (3 months) and is there therefore a chance of a placing to cover that immediate debt pressure and free the company up to focus on cash generation and lowering the net debt position organically going forward?

' (assuming guidance is being met)'

It is. Q2 results were exceptional and Eric informed us, as of 20th July (so almost three weeks into Q3) then NLGM was on target and Singida running ahead of schedule.

Throw in the $6.7m VAT that will be crystallised in the next results and the financials look even better.

This must be Shishir's way of saying to the market 'all is fine, all is good, all will be revealed soon'